UM

Browse/Search Results:  1-9 of 9 Help

Filters    
Selected(0)Clear Items/Page:    Sort:
Novel Compound-Target Interactions Prediction for the Herbal Formula Hua-Yu-Qiang-Shen-Tong-Bi-Fang Journal article
CHEMICAL & PHARMACEUTICAL BULLETIN, 2019,Volume: 67,Issue: 8,Page: 778-785
Authors:  Zihao Wang;  Hui-Heng Lin;  Kegang Linghu;  Huang, Run-Yue;  Guangyao Li;  Huali Zuo;  Yu Hua;  Ging Chan;  Yuanjia Hu
Favorite | View/Download:11/0 | TC[WOS]:1 TC[Scopus]:0 | Submit date:2020/03/10
In-silico Target Identification  Herbal Formula  Hua-yu-qiang-shen-tong-bi-fang  Natural Product  Network Link Prediction  
Active Ingredients and Action Mechanisms of Yi Guan Jian Decoction in Chronic Hepatitis B Patients with Liver Fibrosis Journal article
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2019
Authors:  Guangyao Li;  Yuan Zhou;  Daniel Man-Yuen Sze;  Chao Liu;  Qianru Zhang;  Zihao Wang;  Hua Yu;  Ging Chan;  Zhongdao Wu;  Shibing Su;  Yuanjia Hu
Favorite | View/Download:21/0 | TC[WOS]:1 TC[Scopus]:0 | Submit date:2020/03/10
Research and development of anti-Alzheimer's disease drugs: an update from the perspective of technology flows Journal article
EXPERT OPINION ON THERAPEUTIC PATENTS, 2018,Volume: 28,Issue: 4,Page: 341-350
Authors:  Liu, Kunmeng;  Lin, Hui-Heng;  Pi, Rongbiao;  Mak, Shinghung;  Han, Yifan;  Hu, Yuanjia
Favorite | View/Download:18/0 | TC[WOS]:4 TC[Scopus]:0 | Submit date:2018/10/30
Alzheimer's disease  patent  technology flow  citation network  research and development  
Research and development of anti-Alzheimer's disease drugs: an update from the perspective of technology flows Journal article
EXPERT OPINION ON THERAPEUTIC PATENTS, 2018,Volume: 28,Issue: 4,Page: 341-350
Authors:  Liu, Kunmeng;  Lin, Hui-Heng;  Pi, Rongbiao;  Mak, Shinghung;  Han, Yifan;  Hu, Yuanjia
Favorite | View/Download:4/0 | TC[WOS]:4 TC[Scopus]:0 | Submit date:2018/10/31
Alzheimer's disease  patent  technology flow  citation network  research and development  
Research and development of anti-Alzheimer's disease drugs: an update from the perspective of technology flows Journal article
EXPERT OPINION ON THERAPEUTIC PATENTS, 2018,Volume: 28,Issue: 4,Page: 341-350
Authors:  Liu, Kunmeng;  Lin, Hui-Heng;  Pi, Rongbiao;  Mak, Shinghung;  Han, Yifan;  Hu, Yuanjia
Favorite | View/Download:5/0 | TC[WOS]:4 TC[Scopus]:0 | Submit date:2018/10/31
Alzheimer's disease  patent  technology flow  citation network  research and development  
Research and development of anti-Alzheimer's disease drugs: an update from the perspective of technology flows Journal article
EXPERT OPINION ON THERAPEUTIC PATENTS, 2018,Volume: 28,Issue: 4,Page: 341-350
Authors:  Liu, Kunmeng;  Lin, Hui-Heng;  Pi, Rongbiao;  Mak, Shinghung;  Han, Yifan;  Hu, Yuanjia
Favorite | View/Download:18/0 | TC[WOS]:4 TC[Scopus]:0 | Submit date:2018/10/30
Alzheimer's disease  patent  technology flow  citation network  research and development  
Global patent landscape of programmed cell death 1: implications of the rapid expansion Journal article
EXPERT OPINION ON THERAPEUTIC PATENTS, 2018,Volume: 28,Issue: 1,Page: 69-80
Authors:  Kong, Xiangjun;  Zhang, Qianru;  Lai, Yunfeng;  Hu, Hao;  Chen, Xin;  Hu, Yuanjia
Favorite | View/Download:27/0 | TC[WOS]:2 TC[Scopus]:0 | Submit date:2018/10/30
Programmed Cell Death 1 (Pd-1)  Patent Landscape  Patent Citation Network  Co-patent  Technology Flow  Immunotherapy  
Academic Career Progression of Chinese-Origin Pharmacy Faculty Members in Western Countries Journal article
PHARMACY, 2018,Volume: 6,Issue: 4
Authors:  Weixiang Zhang;  Hao Zhong;  Yitao Wang;  Ging Chan;  Yuanjia Hu;  Hao Hu;  Defang Ouyang
Favorite | View/Download:12/0 | TC[WOS]:0 TC[Scopus]:0 | Submit date:2020/03/26
Academic  Underrepresented Minorities  Chinese-origin Faculty  Academic Career Progression  Pharmacy  
Evolving patterns in a collaboration network of global R&D on monoclonal antibodies Journal article
MABS, 2017,Volume: 9,Issue: 7,Page: 1041-1051
Authors:  Kong, Xiangjun;  Wan, Jian-bo;  Hu, Hao;  Su, Shibing;  Hu, Yuanjia
Favorite | View/Download:15/0 | TC[WOS]:0 TC[Scopus]:0 | Submit date:2018/10/30
Collaboration Network  Dedicated Biotechnology Firms  Inter-organizational Relationship  Mergers And Acquisitions  Monoclonal Antibodies  Network Evolution  r&d  Pharmaceutical Companies  Technological Innovation